Timing of Subcostal TAPB Combined With Rectus Sheath Block for Postoperative Pain After Laparoscopic Cholecystectomy
Effect of Timing of Ultrasound-Guided Subcostal Transversus Abdominis Plane Block Combined With Rectus Sheath Block on Postoperative Pain in Laparoscopic Cholecystectomy: A Prospective Randomized Controlled Trial
1 other identifier
interventional
96
1 country
1
Brief Summary
This prospective randomized controlled trial aims to evaluate whether the timing of ultrasound-guided subcostal transversus abdominis plane (TAP) block combined with rectus sheath block (RSB) affects postoperative pain in patients undergoing laparoscopic cholecystectomy. Participants will be randomly assigned to receive the combined regional blocks either before surgical incision or after completion of surgery. The primary outcome is postoperative pain intensity measured using a numerical rating scale. Secondary outcomes include opioid consumption, incidence of postoperative nausea and vomiting, and other recovery parameters. The results of this study may help optimize the timing of abdominal wall blocks to improve postoperative analgesia and recovery following laparoscopic cholecystectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable postoperative-pain
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2026
CompletedStudy Start
First participant enrolled
February 23, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 15, 2027
February 27, 2026
February 1, 2026
11 months
February 22, 2026
February 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maximum postoperative pain intensity within 24 hours
The highest postoperative pain intensity measured using an 11-point numeric rating scale (NRS; 0 = no pain, 10 = worst pain imaginable) during the first 24 hours after surgery, assessed at 1, 6, 12, and 24 hours postoperatively.
Within 24 hours after surgery
Secondary Outcomes (3)
Maximum postoperative pain intensity during post-anesthesia care unit stay
During the post-anesthesia care unit stay
Cumulative rescue opioid consumption within 24 hours
Within 24 hours after surgery
Incidence of postoperative nausea and vomiting
Within 24 hours after surgery
Study Arms (2)
Pre-incisional Block Group
EXPERIMENTALParticipants receive ultrasound-guided subcostal transversus abdominis plane (TAP) block combined with rectus sheath block (RSB) after induction of general anesthesia and before surgical incision.
Postoperative Block Group
EXPERIMENTALParticipants receive ultrasound-guided subcostal transversus abdominis plane (TAP) block combined with rectus sheath block (RSB) after completion of surgery and before emergence from anesthesia.
Interventions
Ultrasound-guided right subcostal transversus abdominis plane (TAP) block combined with bilateral rectus sheath block (RSB) is performed under sterile conditions using local anesthetic for postoperative analgesia.
Eligibility Criteria
You may qualify if:
- Elective laparoscopic cholecystectomy
- Adults aged 18 to 80 years
- Ability to understand the study procedures and provide informed consent
- American Society of Anesthesiologists (ASA) physical status I-III
You may not qualify if:
- Presence of significant pain unrelated to the target disease that may interfere with pain assessment
- Known allergy or contraindication to study medications (ropivacaine, acetaminophen, nefopam, or pethidine)
- Planned single-port laparoscopic cholecystectomy
- American Society of Anesthesiologists (ASA) physical status IV or higher
- Infection of the abdominal wall or skin at the injection site, or anatomical abnormalities of the abdominal wall
- Major neurological, psychiatric, or systemic diseases that may affect pain perception, treatment response, or study evaluation
- Requirement for postoperative mechanical ventilation
- Pregnancy or breastfeeding
- Considered unsuitable for the study by the investigator
- Refusal to participate or inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nowon Eulji University Hospital
Seoul, 01830, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hye-yeon Cho
Nowon Eulji University Hospital, Eulji University College of Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants and outcome assessors will be blinded to group allocation. The anesthesiologist performing the block will not be blinded due to the nature of the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
February 22, 2026
First Posted
February 27, 2026
Study Start
February 23, 2026
Primary Completion (Estimated)
January 15, 2027
Study Completion (Estimated)
January 15, 2027
Last Updated
February 27, 2026
Record last verified: 2026-02